BIRC5 and neoplasm: Inaddition, it has been well studied that activation of thecheckpoint kinase 2 (CHK2) due to DNA damage outcomes inrapid release of survivin from the mitochondria and thereforeinhibiting cell death that upholds tumor cell survival.